News Agency
Men's Weekly

Technoderma Medicines Advances TDM-180935 Atopic Dermatitis Clinical Program with Phase 2 Trial

  • Written by PR Newswire

CHENGDU, China, April 29, 2024 /PRNewswire/ -- Technoderma Medicines, Inc. ("the Company"), a clinical stage biopharmaceutical company, is pleased to report the Company has begun dosing patients in its Phase 2a clinical trial (NCT06363461) of topical TDM-180935 ointment....

Read more: Technoderma Medicines Advances TDM-180935 Atopic Dermatitis Clinical Program with Phase 2 Trial

The Power of Creative Agencies in Shaping Modern Brands

In today’s digital era, businesses are constantly seeking innovative ways to connect with their audiences and stand out in a crowded marketplace. Creative agencies have emerged as key partners in achieving these goals. By combining design, strategy, content creation, and... Read more

Writers Wanted



NewsServices.com

Content & Technology Connecting Global Audiences

More Information - Less Opinion